일부 동물성 한약재의 독성과 안전성등급화 - 봉독, 사독, 반묘와 오공을 중심으로 -
Toxicity and safety classification of 4 animal medicines - Focusing on venoms from bee, snake, blister beetle and scolopendrid -
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives : About 13% of the medicines used by traditional korean medicines(TKM), are called animal medicines and are derived from non-herbal sources such as animals and insects. However, the clinical use of these preparations from animal medicines is often based on tradition and belief, rather than on evidence of toxicity and efficacy. As a result, animal medicines containing toxin have caused serious problems from injecting patients with venom. Here, various venoms frequently used as TKM were reviewed in terms of their instinct toxity and tried to estimate their safety classification. Methods : The estimation of safety classification was based on human equivalent dose(HED)-based MOS (margin of safety) and clinical dose applied for patients. Results and Conclusions : Except that of snake venom due to no clinical dose, they were evaluated as class 3 for bee venom, class 4 for cantharidin, toxin from blister beetle, and class 1 for venom from scolopendrid. In conclusion, animal medicines showed a wide range of safety classification from class 1 to class 4. This wide range is estimated to result from extremely limited applications of each venom for patients because of their strong toxicity. However, it should be cautious for application in clinics since animal medicines can produce anaphylactic reactions particularly after veinous administration even with a tiny amount of venom.
Abstract
Objectives : About 13% of the medicines used by traditional korean medicines(TKM), are called animal medicines and are derived from non-herbal sources such as animals and insects. However, the clinical use of these preparations from animal medicines is often based on tradition and belief, rather than on evidence of toxicity and efficacy. As a result, animal medicines containing toxin have caused serious problems from injecting patients with venom. Here, various venoms frequently used as TKM were reviewed in terms of their instinct toxity and tried to estimate their safety classification. Methods : The estimation of safety classification was based on human equivalent dose(HED)-based MOS (margin of safety) and clinical dose applied for patients. Results and Conclusions : Except that of snake venom due to no clinical dose, they were evaluated as class 3 for bee venom, class 4 for cantharidin, toxin from blister beetle, and class 1 for venom from scolopendrid. In conclusion, animal medicines showed a wide range of safety classification from class 1 to class 4. This wide range is estimated to result from extremely limited applications of each venom for patients because of their strong toxicity. However, it should be cautious for application in clinics since animal medicines can produce anaphylactic reactions particularly after veinous administration even with a tiny amount of venom.
참고문헌 (94)
- 이선동, "한약독성학 I", pp.16~22 (2012), 한국학술정보(주)
- Still J, "Use of animal products in traditional Chinese medicine: environmental impact and health hazards", Complementary Therapies in Medicine, 11, pp.118~122 (2003)
- 서부일, "임상한방본초학" (2004), 영림사
- 박영철, "독성학의 분자-생화학적 원리", pp.30~31 (2010), 한국학술정보(주)
- 박영철, "한약의 안전성 등급화를 위한 evidence-based approach", 대한예방한의학회지, 17(3), pp.19~31 (2013), 대한예방한의학회
- 박영철, "한약의 안전성 등급화를 통한 근거중심실용의학적 연구(1) - Aristolochic acid 함유 한약재를 중심으로 -", 대한한의학회지, 35(1), pp.114~123 (2014), 대한한의학회
- 박영철, "독성대사체를 생성하는 다빈도사용 한약재의 안전성등급화 - 천궁, 당귀, 감초, 숙지황을 중심으로 -", 대한예방한의학회지, 19(2), pp.123~133 (2015), 대한예방한의학회
- 이용석, "봉독을 이용한 무작위배정 임상연구의 국내 현황", 한방재활의학과학회지, 23(3), pp.87~106 (2013), 한방재활의학과학회
- Shipolini RA, "Handbook of natural toxins, Vol. 2", pp.49~85 (1984), Marcel Dekker
- Sherman RA, "Medicine, Insects", pp.618~620 (2009)
- Mahmoud Abdu Al-Samie, "Studies on Bee Venom and Its Medical Uses", International Journal of Advancements in Research & Technology, 1(2), pp.1~15 (2012)
- Dotimas EM, "Honeybee venom", Bee World, 68(2), pp.51~70 (1987)
- Roeder T, "Octopamine in invertebrates", Prog. Neurobiol, 59, pp.533~561 (1999)
- Jiangtao Dong, "High-performance liquid chromatography combined with intrinsic fluorescence detection to analyse melittin in individual honeybee (Apis mellifera) venom sac", Journal of Chromatography B, 1002, pp.139~143 (2015)
- Terwilliger TC, "The structure of melittin in the form I crystals and its implication for melittin’s lytic and surface activities", Biophys. J, 37, pp.353~361 (1982)
- Gajski G, "Melittin: A lytic peptide with anticancer properties", Environ Toxicol Pharmacol, 36(2), pp.697~705 (2013)
- Son DJ, "Therapeutic application of antiarthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds", Pharmacol. Ther, 115, pp.246~270 (2007)
- Hao J, "Roles of peripheral mitogenactivated protein kinases in melittin-induced nociception and hyperalgesia", Neuroscience, 152, pp.1067~1075 (2008)
- Tessier DC, "Ehanced secretion from insect cells of a foreign protein fused to the honeybee melittinsignal peptide", Gene, 98(2), pp.177~183 (1991)
- Clapp LE, "Phospholipase A2-induced neurotoxicity in vitro and in vivo in rats", Brain Res, 693, pp.101~111 (1995)
- Barker SA, "Characterization of the products of the action of bee venom hyaluronidase", Nature, 199, pp.693~694 (1963)
- Hider RC, "A proposal for the structure of apamin", FEBS Lett, 111, pp.189~193 (1990)
- Zhang L, "Apamin depresses selectively the after-hyperpolarization of cat spinal motoneurons", Neuroscience Letters, 74(1), pp.58~62 (1987)
- Hugues M, "Apamin as a selective blocker of the calcium-dependent potassium channel in neuroblastoma cells: voltage-clamp and biochemical characterization of the toxin receptor", Proc. Natl. Acad. Sci. U.S.A, 79, pp.1308~1312 (1982)
- Banks BE, "Anti-inflammatory activity of bee venom peptide 401 (mast cell degranulating peptide) and compound 48", 80 results from mast cell degranulation in vivo, 1990, pp.99, 350~354
- Kondo T, "K+ channel involvement in induction of synaptic enhancement by mast cell degranulating (MCD) peptide", Neurosci. Res, 13, pp.207~216 (1992)
- Bidard JN, "Analogies and differences in the mode of action and properties of binding sites (localization and mutual interactions) of two K+ channel toxins. MCD peptide and dendrotoxin I", Brain Res, 495, pp.45~57 (1989)
- Shkenderov S, "Adolapin: a newly isolated analgetic and antiinflammatory polypeptide from bee venom", Toxicon, 20, pp.317~321 (1982)
- Koburova KL, "Further investigation on the antiinflammatory properties of adolapin—bee venom polypeptide", Acta Physiol. Pharmacol. Bulg, 11, pp.50~55 (1985)
- Kwon YB, "The watersoluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats", Life Science, 71, pp.191~204 (2002)
- Sharma HC, "Medicinal properties of some lesser known but important bee products", Proc. 2nd Int. Conf. Apiculture in Trop. Climates, pp.694~702 (1983)
- Krell R, "Value-added products from beekeeping. SAO Agricultural Services Bulletin", Food and Agriculture Organization of the United Nation, ~ (1996)
- Mandal MD, "Honey: its medicinal property and antibacterial activity", Asian Pacific Journal of Tropical Biomedicine, 1(2), pp.154~160 (2011)
- Hoffman DR, "Honey bee venom allergy:immunological studies of systemic and large local reactions", Ann. Allergy, 41, pp.278~282 (1978)
- Smallheer BA, "Bee and Wasp Stings : Reactions and Anaphylaxis", Critical Care Nursing Clinics of North America, 25(2), pp.151~164 (2013)
- Schmidt JO, "The Hive and the Honey Bee" (1999), Hamilton
- Simons FE, "Anaphylaxis", J Allergy Clin Immunol, 125(2 Suppl 2), pp.S161~S181 (2010)
- Simons FE, "Practical allergy (PRACTALL) report: risk assessment in anaphylaxis", Allergy, 63, pp.35~37 (2008)
- Chen CY, "Comparison of anti-inflammatory, analgesic activities, anaphylactogenicity and acute toxicity between bee venom and its peptides", Zhongguo Zhong Xi Yi Jie He Za Zhi, 13, pp.226~227 (1993)
- "Allergy definition"[URL]
- Phyllis AB, "Prescription for Nutritional Healing" (2000), AVERY
- Golden D, "Anaphylaxis to Insect Stings", Immunology and Allergy Clinics of North America, 35(2), pp.287~302 (2015)
- Tyson C. Brown, "The sting of the honeybee: an allergic perspective", Ann Allergy Asthma Immunol, 107, pp.463~471 (2011)
- Manivannan V, "Epinephrine use and outcomes in anaphylaxis patients transported by emergency medical services", American Journal of Emergency Medicine, 32, pp.1097~1102 (2014)
- Rose A, "Bees in balance" (1994), Starboint Enterprises Ltd
- Cuende E, "Beekeeper’ arthropathy", J. Rheumatol, 26, pp.2684~2690 (1999)
- Schumacher MJ, "Lethality of “killer” bee stings", Nature, 337, pp.413~ (1989)
- Won CH, "Efficacy of bee venom injection for osteoarthritis patients", J Korean Rheum assoc, 6, pp.218~226 (1999)
- 이종선, "건조밀봉독(아피톡신주) 주사에 의한 이물 육아종", 대한피부과학회지, 49(10), pp.943~947 (2011), 대한피부과학회
- Bauchot R, "Snakes: A Natural History", pp.194~209 (1994), Sterling Publishing Co, Inc
- Fry BG, "The toxicogenomic multiverse:convergent recruitment of proteins into animal venoms", Annu. Rev. Genomics Hum. Genet, 10, pp.483~511 (2009)
- Fry BG, "The structural and functional diversification of the Toxicofera reptile venom system", Toxicon, 60, pp.434~448 (2012)
- Bottrall JL, "Proteolytic activity of Elapid and Viperid Snake venoms and its implication to digestion", Journal of Venom Research, 1, pp.18~28 (2010)
- Stewart CJ, "Snake bite in Australia: fi rst aid and envenomation management", Accident Emergency Nursing, 11, pp.106~111 (2003)
- Campbell CH, "Handbook of Experimental Pharmacology, Snake Venoms", pp.898~921 (1979), Springer
- Lu Q, "Snake venoms and hemostasis", J Thromb Haemost, 3, pp.1791~1799 (2005)
- Rodríguez-Ithurralde D, "Fasciculin, a powerful anticholinesterase polypeptide from Dendroaspis angusticeps venom", Neurochemistry International, 5(3), pp.267~274 (1983)
- Harel M, "Crystal structure of an acetylcholinesterase–fasciculin complex : interaction of a three-fingered toxin from snakevenom with its target", Structure, 3(12), pp.1355~1366 (1995)
- Bolioli B, "Neurochemical and behavioral correlates of unilateral striatal acetylcholinesterase inhibition by fasciculin in rats", Brain Research, 504(1), pp.1~6 (1989)
- Du XY, "Qphioluxin, a convulxinlike C-type lectin from Ophiophagus hannah(King cobra) is a powerful platelet activator via glycoprotein VI", J. Biol. Chem, 277, pp.35124~35132 (2002)
- Lee WH, "Isolation and properties of a blood coagulation factor X activator from the venom of king cobra(Ophiophagus hannah)", Toxicon, 33, pp.1263~1276 (1995)
- Jin Y, "Molecular characterization of L-amino acid oxidasefrom king cobra venom", Toxicon, 50, pp.479~489 (2007)
- Chen YH, "Snake venom cardiotoxin induces G-actin polymerization", Biochimica et Biophysica Acta(BBA)-General Subjects, 966(2), pp.266~268 (1988)
- Dufton MJ, "International Encyclopaedia of Pharmacology and Therapeutics, Snake Toxins", pp.259~302 (1991), Pergamon Press
- Broad AJ, "The lethality in mice of dangerous Australian and other snake venoms", Toxicon, 17, pp.664~667 (1979)
- Minton S, "Venomous Reptiles" (1969), Scribners
- 노희목, "斑猫와 加工斑猫의 單回投與 독성에 대한 비교연구", 대한본초학회지, 24(3), pp.1~12 (2009), 대한본초학회
- Liu R, "Investigation of two blood proteins binding to Cantharidinand Norcantharidin by multispectroscopic and chemometrics methods", Journal of Luminescence, 157, pp.398~410 (2015)
- Mebs D, "Cantharidin and demethyl cantharidin (palasonin)content of blister beetles (Coleoptera:Meloidae) from southern Africa", Toxicon, 53, pp.466~468 (2009)
- Moed L, "Cantharidin revisited: A blistering defense of an ancient medicine (PDF)", Archives of Dermatology, 137(10), pp.1357~1360 (2001)
- Phong Huy Duc Dinh, "Validation of the cantharidin-induced skin blister as an in vivo model of inflammation", British Journal of Clinical Pharmacology, 72(6), pp.912~920 (2011)
- Norman N, "A Review: Cantharidin Poisoning", S Afr Farm Pract, 10, pp.70~73 (1989)
- Binder R, "Malpractice-in dermatology", Cutis;Cutaneous Medicine for the Practitioner, 23(5), pp.663~666 (1979)
- Tagwireyi D, "Cantharidin poisoning due to Blister beetle ingestion", Toxicon, 38, pp.1865~1869 (2000)
- Fisch HP, "Lesions of the kidney and efferent urinary tract due to cantharidin", Schweiz. Med. Wschr, 108, pp.1664~1667 (1978)
- Carver JD, "Cantharidin poisoning", Brit Med J, 2, pp.1386~1387 (1954)
- Presto AJ, "A dose of Spanish Fly", J Am Med Assoc, 214(3), pp.591~592 (1970)
- Nickolls LC, "Poisoning by cantharidin", Brit Med J, 2, pp.1384~1386 (1954)
- Ratcliffe NA, "Insect natural products and processes: New treatments for human disease", Insect Biochemistry and Molecular Biology, 41(10), pp.747~769 (2011)
- Sánchez-Barbudo IS, "Possible cantharidin poisoning of a great bustard(Otis tarda)", Toxicon, 59, pp.100~103 (2012)
- 한의사 의료분쟁 사례분석 및 대처방안 연구, "대한한의학회", 123~124 (2013)
- 신승우, "오공독에 관한 문헌적 고찰", 대한면역약침학회지, 1(1), pp.81~91 (2012)
- Noda N, "A novel quinoline alkaloid possessing a 7-benzyl group from the centipede. Scolopendra subspinipes", Chemical & Pharmaceutical Bulletin, 49, pp.930~931 (2001)
- Zlotkin E, "Comprehensive Molecular Insect Science;5.6 – Scorpion Venoms", Pharmacology, 5, pp.173~220 (2005)
- Cooper AM, "Variation in venom yield and protein concentration of the centipedes Scolopendrapolymorpha and Scolopendra subspinipes", Toxicon, 82, pp.30~51 (2014)
- Bush SP, "Centipede envenomation", Wilderness &Environmental Medicine, 12(2), pp.93~99 (2001)
- Bettini S, "Handbuch der experimentellen Pharmakologie" (1978)